Evaluation of an ex vivo murine local lymph node assay: Multiple endpoint comparison

Journal of Applied Toxicology

Volumn 26, Issue 4, 2006, Pages 333-340

  Piccotti, Joseph R ^a   Knight, Stephanie A ^a   Gillhouse, Kimberly ^a   LaGattuta, Mark S ^a   Bleavins, Michael R ^a  

^a PFIZER INC   (United States)

Author keywords

BALB c mice; Ex vivo; Hexylcinnamic aldehyde; LLNA; Methyl salicylate; Oxazolone; Skin sensitization; Topical

Indexed keywords

ALDEHYDE DERIVATIVE; HEXYLCINNAMIC ALDEHYDE; OXAZOLONE; SALICYLIC ACID METHYL ESTER; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CELL ISOLATION; CELL PROLIFERATION; CONTACT SENSITIZATION; LOCAL LYMPH NODE ASSAY; LYMPH NODE CELL; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ACROLEIN; ADMINISTRATION, TOPICAL; ANIMALS; BROMODEOXYURIDINE; CELL PROLIFERATION; CELLS, CULTURED; DERMATITIS, CONTACT; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDPOINT DETERMINATION; FEMALE; IRRITANTS; LOCAL LYMPH NODE ASSAY; LYMPH NODES; MICE; MICE, INBRED BALB C; ORGAN SIZE; OXAZOLONE; REPRODUCIBILITY OF RESULTS; SALICYLATES; THYMIDINE;

ANIMALIA; MURINAE;

EID: 33745972347     PISSN: 0260437X     EISSN: 10991263     Source Type: Journal    
DOI: 10.1002/jat.1145     Document Type: Article

References (32)

1. Basketter DA, Blaikie L, Dearman RJ, Kimber I, Ryan CA, Gerberick GF, Harvey P, Evans P, White IR, Rycroft RJG. 2000. Use of the local lymph node assay for the estimation of relative contact allergic potency. Contact Dermatitis 42: 344-348.
2. Basketter DA, Gerberick GF, Kimber I. 2001. Measurement of allergic potency using local lymph node assay. Trends Pharmacol. Sci. 22: 264-265.
3. Buehler EV. 1996. Nonspecific hypersensitivity: False-positive responses with the use of Freund's complete adjuvant. Contact Dermatitis 34: 111-114.
4. Committee for Proprietary Medicinal Products (CPMP). 2001. Note for Guidance on Non-clinical Local Tolerance Testing of Medicinal Products. CPMP/SWP/2145/00.
5. Dean JH, Twerdok LE, Tice RR, Sailstad DM, Hattan DG, Stokes WS. 2001. ICCVAM evaluation of the murine local lymph node assay. II. Conclusions and recommendations of an independent scientific peer review panel. Reg. Toxicol. Pharmacol. 34: 258-273.
6. Dearman RJ, Basketter DA, Kimber I. 1999. Local lymph node assay: Use in hazard and risk assessment. J. Appl. Toxicol. 19: 299-306.
7. Dearman RJ, Wright ZM, Basketter DA, Ryan CA, Gerberick GF, Kimber I. 2001. The suitability of hexyl cinnamic aldehyde as a calibrant for the murine local lymph node assay. Contact Dermatitis 44: 357-361.
8. Food and Drug Administration, Center for Drug Evaluation and Research. 2002. Guidance for Industry: Immunotoxicology Evaluation of Investigational New Drugs. FDA: US Department of Health and Human Sciences, USA.
9. Gerberick GF, Cruse LW, Ryan CA. 1999. Local lymph node assay: Differentiating allergic and irritant responses using flow cytometry. Methods 19: 48-55.
10. Gerberick GF, Cruse LW, Ryan CA, Hulette BC, Chaney JG, Skinner RA, Dearman RJ, Kimber I. 2002. Use of B cell marker (B220) to discriminate between allergens and irritants in the local lymph node assay. Toxicol. Sci. 68: 420-428.
11. Gerberick GF, Robinson MK, Ryan CA, Dearman RJ, Kimber I, Basketter DA, Wright Z, Marks JG. 2001. Contact allergenic potency: Correlation of human and local lymph node assay data. Am. J. Contact Dermat. 12: 156-161.
12. Gerberick GF, Ryan CA, Kimber I, Dearman RJ, Lea LJ, Basketter DA. 2000. Local lymph node assay: Validation assessment for regulatory purposes. Am. J. Contact Dermal. 11: 3-18.
13. Haneke KE, Tice RR, Carson BL, Margolin BH, Stokes WS. 2001. ICCVAM evaluation of the murine local lymph node assay. III. Data analysis completed by the National Toxicology Program Interagency Center for the Evaluation of Alternative Toxicological Methods. Reg. Toxicol. Pharmacol. 34: 274-286.
14. Ikarashi Y, Tsuchiya T, Nakamura A. 1992. Detection of contact sensitivity of metal salts using the murine local lymph node assay. Toxicol. Lett. 62: 53-61.
15. Ikarashi Y, Tsuchiya T, Nakamura A. 1993. A sensitive mouse lymph node assay with two application phases for detection of contact allergens. Arch. Toxicol. 67: 629-636.
16. Kimber I, Basketter DA, Berthold K, Bulter M, Garrigue J-L, Lea L, Newsome C, Roggeband R, Steiling W, Stropp G, Waterman S, Wiemann C. 2001. Skin sensitization testing in potency and risk assessment. Toxicol. Sci. 59: 198-208.
17. Kimber I, Hilton J, Dearman RJ, Gerberick GF, Ryan CA, Basketter DA, Lea L, House RV, Ladies GS, Loveless SE, Hasting KL. 1998. Assessment of the skin sensitization potential of topical medicaments using the local lymph node assay: An interlaboratory evaluation. J. Toxicol. Environ. Health 53: 563-579.
18. Kimber I, Weisenberger C. 1989. A murine local lymph node assay for identification of contact allergens: Assay development and results of an initial validation study. Arch. Toxicol. 63: 274-282.
19. Kligman AM, Basketter DA. 1995. A critical commentary and updating of the guinea pig maximization test. Contact Dermatitis 32: 129-134.
20. Kuricova M, Tulinska J, Kubova J, Liskova A, Fuortes L. 2001. AIlergenicity testing of supermethrin, phenoxyacetic acid and DNCB using in vivo and in vitro modifications of the local lymph node assay, maximization and epicutaneous testing. J. Appl. Toxicol. 21: 257-262.
21. Loveless SE, Ladies GS, Gerberick GF, Ryan CA, Basketter DA, Scholes EW, House RV, Hilton J, Dearman RJ, Kimber I. 1996. Further evaluation of the local lymph node assay in the final phase of an international collaborative trial. Toxicology 108: 141-152.
22. Manetz TS, Meade BJ. 1999. Development of a flow cytometry assay for the identification and differentiation of chemicals with the potential to elicit irritation, IgE-mediated, or T cell-mediated hypersensitivity responses. Toxicol. Sci. 48: 206-217.
23. Monteliiis J, Wahlkvist H, Boman A, Fernstrom P, Grabergs L, Wahlberg JE. 1994. Experience with the murine local lymph node assay: Inability to discriminate between allergens and irritants. Acta Derm. Venereol. 74: 22-27.
24. National Institute of Environmental Health Sciences. 1999. The Murine Local Lymph Node Assay: A Test Method for Assessing the Allergic Contact Dermatitis Potential of Chemicals/Compounds. NIH Publication 99-4494. NIH: Research Triangle Park, NC, USA.
25. OECD guideline for testing of chemicals. No 429. 2002. Skin Sensitization: Local Lymph Node Assay. (Adopted 24 April 2002) OECD: Paris.
26. Piccotti JR, LaGattuta MS, Knight SA, Gonzales AJ, Bleavins MR. 2005. Induction of apoptosis by the cationic amphiphilic drugs amiodarone and imipramine. Drug Chem. Toxicol. 28: 117-133.
27. Sailstad DM. 2002. Murine local lymph node assay: An alternative test method for skin hypersensitivity. Lab. Anim. 31: 36-41.
28. Sailstad DM, Hattan D, Hill RN, Stokes WS. 2001. ICCVAM evaluation of the murine local lymph node assay. I. The ICCVAM review process. Reg. Toxicol. Pharmacol. 34: 249-257.
29. Sailstad DM, Krishnan SD, Tepper JS, Doerfler DL, Selgrade MK. 1995. Dietary vitamin A enhances sensitivity of the local lymph node assay. Toxicology 96: 157-163.
30. Takeyoshi M, Noda S, Yamazaki S, Kakishima H, Yamasaki K, Kimber I. 2004. Assessment of the skin sensitization potency of eugenol and its dimers using a non-radioactive modification of the local lymph node assay. J. Appl. Toxicol. 24: 77-81.
31. Takeyoshi M, Yamasaki K, Yakabe Y, Takatsuki M. Kimber I. 2001. Development of non-radioisotope endpoint of murine local lymph node assay based on 5-bromo-2′-deoxyuridine (BrdU) incorporation. Toxicol. Lett. 119: 203-208.
32. Woolhiser MR, Munson AE, Meade BJ. 2000. Comparison of mouse strains using the local lymph node assay. Toxicology 146: 221-227.